209 related articles for article (PubMed ID: 21354054)
41. Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer.
Link T; Kuhlmann JD; Kobelt D; Herrmann P; Vassileva YD; Kramer M; Frank K; Göckenjan M; Wimberger P; Stein U
Mol Oncol; 2019 May; 13(5):1268-1279. PubMed ID: 30927479
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
[TBL] [Abstract][Full Text] [Related]
43. The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.
Yuan TM; Liang RY; Hsiao NW; Chuang SM
Oncol Rep; 2014 Dec; 32(6):2307-18. PubMed ID: 25310523
[TBL] [Abstract][Full Text] [Related]
44. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.
Kortüm B; Radhakrishnan H; Zincke F; Sachse C; Burock S; Keilholz U; Dahlmann M; Walther W; Dittmar G; Kobelt D; Stein U
Oncogene; 2022 Sep; 41(39):4446-4458. PubMed ID: 36008464
[TBL] [Abstract][Full Text] [Related]
45. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
46. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
[TBL] [Abstract][Full Text] [Related]
47. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer.
de Silva Rudland S; Martin L; Roshanlall C; Winstanley J; Leinster S; Platt-Higgins A; Carroll J; West C; Barraclough R; Rudland P
Clin Cancer Res; 2006 Feb; 12(4):1192-200. PubMed ID: 16489073
[TBL] [Abstract][Full Text] [Related]
48. Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.
Kim JH; Kim CN; Kim SY; Lee JS; Cho D; Kim JW; Yoon SY
Oncol Rep; 2009 Jul; 22(1):41-7. PubMed ID: 19513503
[TBL] [Abstract][Full Text] [Related]
49. Expression status of S100A14 and S100A4 correlates with metastatic potential and clinical outcome in colorectal cancer after surgery.
Wang HY; Zhang JY; Cui JT; Tan XH; Li WM; Gu J; Lu YY
Oncol Rep; 2010 Jan; 23(1):45-52. PubMed ID: 19956863
[TBL] [Abstract][Full Text] [Related]
50. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
Huang L; Xu Y; Cai G; Guan Z; Cai S
Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787
[TBL] [Abstract][Full Text] [Related]
51. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
Huang H; Zheng HY; Liu ZL; Zhang L
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
[TBL] [Abstract][Full Text] [Related]
52. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
[TBL] [Abstract][Full Text] [Related]
53. S100A4 and metastasis: a small actor playing many roles.
Boye K; Maelandsmo GM
Am J Pathol; 2010 Feb; 176(2):528-35. PubMed ID: 20019188
[TBL] [Abstract][Full Text] [Related]
54. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
Zhang G; Li M; Jin J; Bai Y; Yang C
Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
[TBL] [Abstract][Full Text] [Related]
55. Expression of S100A4, E-cadherin, alpha- and beta-catenin in gastric adenocarcinoma.
Yoon CS; Hyung WJ; Lee JH; Chae YS; Won NH; Yeom BW; Choi JS
Hepatogastroenterology; 2008; 55(86-87):1916-20. PubMed ID: 19102422
[TBL] [Abstract][Full Text] [Related]
56. [Effect of cobalt chloride on S100A4 expression in human gastric cancer cell BGC823].
Hua J; Fu H; Zhang RX; Chen DQ; Yan Y; Chen FJ; Sun KL; Sun XJ
Yi Chuan; 2008 Dec; 30(12):1563-6. PubMed ID: 19073570
[TBL] [Abstract][Full Text] [Related]
57. Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites.
Maelandsmo GM; Flørenes VA; Nguyen MT; Flatmark K; Davidson B
Tumour Biol; 2009; 30(1):15-25. PubMed ID: 19194111
[TBL] [Abstract][Full Text] [Related]
58. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
Li HJ; Chen YX; Wang Q; Zhang YG
Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305
[TBL] [Abstract][Full Text] [Related]
59. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
[TBL] [Abstract][Full Text] [Related]
60. The expression of S100A4 in human pancreatic cancer is associated with invasion.
Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
